×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by RAAB MICHAEL

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSep 26, 2024Sale$6.073,00018,2101,217,608Sep 27, 2024, 04:09 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSep 11, 2024Sale$5.6135,000196,3991,220,608Sep 13, 2024, 04:35 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSep 11, 2024Option Exercise$0.9935,00034,6501,255,608Sep 13, 2024, 04:35 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOAug 27, 2024Sale$6.227,50046,6351,219,509Aug 28, 2024, 05:45 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOAug 20, 2024Sale$5.8632,225188,8481,227,009Aug 22, 2024, 06:24 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOAug 12, 2024Sale$5.711,2297,0181,259,234Aug 14, 2024, 06:16 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOJul 29, 2024Sale$5.6430,000169,3141,260,463Jul 31, 2024, 07:54 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOJul 29, 2024Option Exercise$0.9930,00029,7001,290,463Jul 31, 2024, 07:54 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOJul 15, 2024Sale$5.977,50044,7671,260,463Jul 17, 2024, 05:54 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOJun 28, 2024Sale$6.592,31015,2231,267,963Jun 28, 2024, 05:37 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOJun 13, 2024Option Exercise$0.9935,00034,6501,305,273Jun 17, 2024, 06:46 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOJun 13, 2024Sale$6.6535,000232,7431,270,273Jun 17, 2024, 06:46 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOMay 29, 2024Sale$6.727,50050,3901,270,273May 31, 2024, 04:31 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOMay 21, 2024Sale$7.8131,484245,9221,277,773May 23, 2024, 04:13 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOMay 14, 2024Sale$7.993,00023,9701,307,933May 15, 2024, 06:15 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOApr 29, 2024Option Exercise$0.9930,00029,7001,340,933May 01, 2024, 07:59 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOApr 29, 2024Sale$6.4030,000192,0571,310,933May 01, 2024, 07:59 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOApr 15, 2024Sale$7.067,50052,9241,310,933Apr 17, 2024, 04:20 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOApr 01, 2024Sale$7.311,51811,0971,318,433Apr 02, 2024, 04:05 PM
FOLDAMICUS THERAPEUTICS, INC.RAAB MICHAELDirectorMar 05, 2024Option Exercise$2.8015,00042,00083,596Mar 06, 2024, 05:22 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOFeb 20, 2024Sale$8.7522,917200,4391,319,951Feb 22, 2024, 04:58 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEONov 20, 2023Sale$4.3611,36849,589867,868Nov 22, 2023, 05:19 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOAug 21, 2023Sale$3.5511,41940,558876,236Aug 23, 2023, 04:41 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOMay 23, 2023Sale$3.6511,35741,489887,655May 25, 2023, 08:55 AM
FOLDAMICUS THERAPEUTICS, INC.RAAB MICHAELDirectorMar 17, 2023Option Exercise$3.3215,00049,80064,420Mar 21, 2023, 07:41 PM
FOLDAMICUS THERAPEUTICS, INC.RAAB MICHAELDirectorMar 17, 2023Sale$11.334,40849,94360,012Mar 21, 2023, 07:41 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOFeb 21, 2023Sale$3.0013,44940,360896,012Feb 24, 2023, 05:39 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEONov 22, 2022Sale$1.956,21912,120665,518Nov 23, 2022, 04:14 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOAug 31, 2022Buy$0.623,0001,856665,680Sep 01, 2022, 07:03 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOAug 22, 2022Sale$0.986,1466,045662,810Aug 24, 2022, 05:43 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOJun 06, 2022Sale$0.65103,62467,416670,970Jun 08, 2022, 08:00 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOMay 20, 2022Sale$0.676,1244,112772,450May 23, 2022, 04:32 PM
FOLDAMICUS THERAPEUTICS, INC.RAAB MICHAELDirectorMay 02, 2022Option Exercise$4.7915,00071,85051,749May 04, 2022, 07:30 PM
FOLDAMICUS THERAPEUTICS, INC.RAAB MICHAELDirectorMay 02, 2022Sale$6.9915,000104,89136,749May 04, 2022, 07:30 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOFeb 22, 2022Sale$0.676,2294,173775,574Feb 25, 2022, 04:56 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEONov 22, 2021Sale$0.992,6072,586631,803Nov 24, 2021, 04:06 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOAug 20, 2021Sale$1.322,5733,396329,730Aug 24, 2021, 06:06 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOAug 03, 2021Option Exercise$1.64150,343246,563332,303Aug 05, 2021, 05:01 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOAug 03, 2021Option Exercise$0.54267,892144,662482,646Aug 05, 2021, 05:01 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOFeb 22, 2021Sale$6.882,53417,440217,288Feb 24, 2021, 04:39 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSep 15, 2020Sale$5.61106,337596,285104,720Sep 17, 2020, 06:31 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOJul 02, 2020Sale$7.0123,128162,13024,364Jul 06, 2020, 04:47 PM
FOLDAMICUS THERAPEUTICS, INC.RAAB MICHAELDirectorJun 01, 2020Option Exercise$2.815,00014,05020,145Jun 03, 2020, 09:09 PM
FOLDAMICUS THERAPEUTICS, INC.RAAB MICHAELDirectorJun 01, 2020Sale$12.655,00063,26015,145Jun 03, 2020, 09:09 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOJun 01, 2020Sale$7.3323,128169,63546,257Jun 02, 2020, 06:38 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOMay 04, 2020Sale$7.0115,941111,68673,871May 05, 2020, 06:11 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOMay 05, 2020Sale$7.034,48631,53669,385May 05, 2020, 06:11 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOApr 17, 2020Sale$7.029,42866,16989,812Apr 17, 2020, 08:01 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOApr 15, 2020Sale$7.035003,515109,740Apr 17, 2020, 08:01 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOApr 16, 2020Sale$7.0110,50073,64299,240Apr 17, 2020, 08:01 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOMar 02, 2020Option Exercise$1.0811,12312,013219,180Mar 04, 2020, 08:12 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOMar 02, 2020Sale$7.0011,12377,861208,057Mar 04, 2020, 08:12 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOMar 02, 2020Sale$7.0120,428143,284110,240Mar 04, 2020, 08:12 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOFeb 05, 2020Option Exercise$1.0825,00027,000231,828Feb 07, 2020, 06:49 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOFeb 05, 2020Sale$7.3225,000182,928206,828Feb 07, 2020, 06:49 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOJun 04, 2019Sale$2.5410,05425,551254,355Jun 06, 2019, 09:11 PM
FOLDAMICUS THERAPEUTICS, INC.RAAB MICHAELDirectorJun 03, 2019Option Exercise$7.155,00035,75013,895Jun 04, 2019, 04:35 PM
FOLDAMICUS THERAPEUTICS, INC.RAAB MICHAELDirectorJun 03, 2019Sale$11.165,00055,7768,895Jun 04, 2019, 04:35 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOJan 02, 2019Sale$1.7019,64433,418261,409Jan 04, 2019, 07:11 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEONov 13, 2018Sale$2.846,53918,571292,499Nov 15, 2018, 05:41 PM
FOLDAMICUS THERAPEUTICS INCRAAB MICHAELDirectorApr 16, 2018Option Exercise$10.535,00052,65010,814Apr 18, 2018, 06:03 PM
FOLDAMICUS THERAPEUTICS INCRAAB MICHAELDirectorApr 16, 2018Sale$14.415,00072,0575,814Apr 18, 2018, 06:03 PM
FOLDAMICUS THERAPEUTICS INCRAAB MICHAELDirectorJan 02, 2018Option Exercise$15.009,366140,49015,180Jan 04, 2018, 05:14 PM
FOLDAMICUS THERAPEUTICS INCRAAB MICHAELDirectorJan 02, 2018Sale$15.009,366140,4905,814Jan 04, 2018, 05:14 PM
FOLDAMICUS THERAPEUTICS INCRAAB MICHAELDirectorOct 12, 2017Option Exercise$14.2510,000142,53415,814Oct 16, 2017, 09:10 PM
FOLDAMICUS THERAPEUTICS INCRAAB MICHAELDirectorOct 12, 2017Sale$14.2510,000142,5345,814Oct 16, 2017, 09:10 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSep 08, 2015Sale$20.299,785198,54570,385Sep 10, 2015, 04:57 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOAug 18, 2015Sale$20.001,10422,08080,170Aug 27, 2015, 04:47 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOAug 03, 2015Sale$20.003006,00081,247Aug 04, 2015, 07:46 PM
ARDXARDELYX, INC.RAAB MICHAELPresident & CEOJul 28, 2015Sale$20.002,11142,22081,547Jul 30, 2015, 05:23 PM
FOLDAMICUS THERAPEUTICS INCRAAB MICHAELDirectorJun 08, 2015Option Exercise$12.658,936113,0400Jun 09, 2015, 02:20 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe